Ile to Val polymorphism at codon 655 of HER-2 gene and breast cancer risk in Iranian women
- 8 November 2004
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 215 (1) , 83-87
- https://doi.org/10.1016/j.canlet.2004.04.007
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Differential expression of NDF/neuregulin receptors ErbB-3 and ErbB-4 and involvement in inhibition of neuronal differentiationOncogene, 1997
- ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signalingThe EMBO Journal, 1997
- Prognostic value of c-erbB2 overexpression in axillary lymph node positive breast cancer. Results from a randomized adjuvant treatment protocolCancer, 1994
- Prognostic significance of HER-2/neu oncoprotein expression in node-positive breast cancer. The influence of the pattern of immunostaining and adjuvant therapyCancer, 1994
- C-erbB-2 overexpression in primary breast cancer: independent prognostic factor in patients at high riskBreast Cancer Research and Treatment, 1994
- Oncogenic activation of p185neu stimulates tyrosine phosphorylation in vivo.Molecular and Cellular Biology, 1988
- Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cellsCell, 1987
- erb B-2 Is a Potent Oncogene When Overexpressed in NIH/3T3 CellsScience, 1987
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- The Product of the Human c- erb B-2 Gene: a 185-Kilodalton Glycoprotein with Tyrosine Kinase ActivityScience, 1986